Results 91 to 100 of about 10,375 (209)

Prevalence, Etiology, and Antifungal Resistance Profiles of Ocular Fungal Infections in Ghanaian Ophthalmic Patients: A Multicenter Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Ocular fungal infections are an important but often underrecognized cause of ocular morbidity, particularly in resource‐limited settings. Delayed diagnosis and inappropriate treatment can lead to poor visual outcomes and increased disease burden.
Isaiah Osei Duah Junior, Abigail Oforiwaa Boateng, Kwadwo Owusu Akuffo, Lord Gyimah, Kingsley Badu   +4 more
wiley   +1 more source

Learnings from Approved Antibody‐Drug Conjugates: Clinical Pharmacology Perspectives

The Journal of Clinical Pharmacology, Volume 66, Issue 4, April 2026.
Abstract Over the past decade, antibody‐drug conjugates (ADCs) have emerged as promising anti‐cancer therapeutics, with twelve ADCs approved by the FDA. This review evaluates trends in these ADCs, stratified by payloads on doses studied from first‐in‐human (FIH) trials through approval and post‐marketing.
Bhargavi Thalluri, Aarti Sawant, Pavan Vajjah, Karthick Vishwanathan, Shringi Sharma   +4 more
wiley   +1 more source

Management of fungal keratitis: Topical or Systemic therapy?

Vision Pan-America, 2014
Currently, there are no level one evidence-based studies comparing systemic vs topical therapy for the management of fungal keratitis. Information on systemic efficacy alone or in combination with topical use is rare.
Darlene Miller, Eduardo C. Alfonso
doaj   +1 more source

Evaluating quality of patient‐reported outcome measures in keratitis: A systematic review

Optometry and Vision Science, Volume 103, Issue 4, April 2026.
ABSTRACT Purpose To evaluate the quality of existing patient‐reported outcome measures (PROMs) used to assess the impact of keratitis on the quality of life (QoL). Methods A literature search was conducted using Embase, PubMed, Scopus, Web of Science, CINAHL, and PsycINFO. The review included PROMs used to assess the impact of keratitis on QoL. Data on
Haile W. Alemu, Sheela E. Kumaran, Nicole Carnt, Aragaw K. Assaye, Pawan Baral, Konrad Pesudovs   +5 more
wiley   +1 more source

Microbiological Characterization of Baru Nuts From the Cerrado Biome, Brazil

Journal of Food Science, Volume 91, Issue 4, April 2026.
ABSTRACT This study aimed to microbiologically characterize baru nuts, a seed widely consumed in Brazil with growing relevance in the export market. Analyses were conducted for mesophilic and thermophilic aerobic spore‐forming bacteria, total mesophilic aerobes, Enterobacteriaceae, Salmonella, Staphylococcus aureus, lactic acid bacteria, molds, and ...
Clara Mariana Gonçalves Lima, Dionísio Pedro Amorim‐Neto, Bruna Godoi de Castro, Ana Luísa Perini Leme Giordano, Beatriz Machado Dal Pian, Matheus Péricles Silva Láscaris, Luana Cristina da Silva Ramos, Angélica Zaninelli Schreiber, Luisa Freire Colombo, Anderson S. Sant'Ana   +9 more
wiley   +1 more source

Clinical experiences in fungal keratitis caused by Acremonium

, 2014
Seong-Jae Kim,1,2 Yong-Wun Cho,1 Seong-Wook Seo,1,2 Sun-Joo Kim,2,3 Ji-Myong Yoo1,21Department of Ophthalmology, 2Gyeongsang Institute of Health Science, 3Department of Laboratory Medicine, Gyeongsang National University, College of Medicine, Jinju ...
Seo SW, Yoo JM, Cho YW, Kim SJ
core  

What We Can Do in Infectious Keratitis, Except for Conventional Antimicrobial‐Based Therapies: Major Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Infectious keratitis (IK) is classified as a critical ophthalmic emergency, with the potential to result in vision‐impairing complications. The treatment approach involves the use of pharmacological antimicrobial agents in combination with surgical interventions.
Kasra Cheraqpour
wiley   +1 more source

Clinical Characteristics and Treatment Outcomes of Pediatric Fungal Keratitis. [PDF]

Infect Drug Resist
Jing Zhang,1– 3 Huabo Chen,1– 3 Vishal Jhanji,4 Bining Zhang,1– 3 Lixin Xie,1– 3 Yanling Dong1– 3 1Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, People’s Republic of China; 2State ...
Zhang J, Chen H, Jhanji V, Zhang B, Xie L, Dong Y.   +5 more
europepmc   +2 more sources

Fungal Keratitis: Clinical Features, Risk Factors, Treatment, and Outcomes

, 2022
Fungal keratitis (FK) can be challenging to diagnose and treat. In this retrospective case series, FK cases presenting at the University of Pittsburgh Medical Center, Pennsylvania, USA, from 2015 to 2021 were reviewed for ocular risk factors, clinical ...
Vishal Jhanji, Perera, Chandrashan, Kowalski, Regis P., Regis P. Kowalski, Chandrashan Perera, Atta, Sarah, Jhanji, Vishal, Sarah Atta   +7 more
core   +1 more source

Recent advances in diagnosis and management of Mycotic Keratitis

Indian Journal of Ophthalmology, 2016
Mycotic keratitis is a major cause of corneal blindness, especially in tropical and subtropical countries. The prognosis is markedly worse compared to bacterial keratitis.
Prafulla K Maharana, Namrata Sharma, Ritu Nagpal, Vishal Jhanji, Sujata Das, Rasik B Vajpayee   +5 more
doaj   +1 more source